Access to Weight Loss Medications: Ozempic and Beyond
In the age of Ozempic, a crucial question arises: who gets access to these medications and who pays for them?
Millions of adults use popular drugs like Ozempic, Wegovy, and Mounjaro to treat chronic conditions and/or lose weight. These GLP-1 medications have been effective and have also shown potential in curbing alcohol and drug consumption and lowering the risk of heart attacks.
- Ozempic, Wegovy, and Mounjaro are used for weight loss and treating chronic conditions.
- These medications can also reduce alcohol and drug consumption and lower heart attack risk.
Some patients obtain these medications through healthcare providers, while others use online platforms without prescriptions, often at a high cost.
The cost of these medications can be prohibitive, with Ozempic costing up to $1,000 per month without insurance, highlighting the issue of unequal access to these treatments.
Author's summary: Ozempic access and cost raise concerns.